The influence of 5,10 methylenetetrahydrofolate reductase genotypes on enzyme activity in placental tissue

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 106, Issue 11, 1999, Pages 1214-1218

  Daly, Sean F ^a   Molloy, Anne M ^b   Mills, James L ^c   Less, Y Jack ^c   Conley, Mary ^c   Kirke, Peadar N ^d   Weir, Donald G ^b   Scott, John M ^b  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c NICHDNIH   (United States)

^d HEALTH RESEARCH BOARD   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID;

ARTICLE; ENZYME ACTIVITY; FEMALE; GENE MUTATION; GENOTYPE; HEATING; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; METABOLISM; NEURAL TUBE DEFECT; NORMAL HUMAN; PLACENTA; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; FEMALE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PLACENTA; PREGNANCY;

EID: 0032750620     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1999.tb08151.x     Document Type: Article

References (12)

1. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338: 131-137.
2. Czeizel AE., Dudas I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 328: 131-137.
3. Frosst P. Blom HJ, Milos R et al. A candidate genetic risk factor for vascular disease: A common mutation methylene tetrahydrofolate reductase. Nature Genet 1995; 10: 111-113.
4. van der Put NM, Eskes TK, Blom HJ. Is the common 677 C-T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. Q J Med 1997; 90: 111-115.
5. Wilcken DEL. MTHFR 677C-T mutation, folate intake, neural-tube defect and risk of cardiovascular disease. Lancet 1997; 350: 603-604.
6. Whitehead AS, Gallagher P., Mills JL et al. A genetic defect in 5.10 methylenetetrahydrofolate reductase in neural-tube defects. Q J Med 1995; 88: 763-766.
7. van der Put NMJ, Steegers-Theunissen RPM, Frosst P et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995; 346: 1070-1071.
8. Kirke PN, Mills JL, Whitehead AS et al. Methylenetetrahydrofolate reductase mutation and neural tube defects. Lancet 1996; 348: 1037-1038.
9. Molloy AM, Daly S, Mills JL et al. Thermolabile variant of 5,10 methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet 1997; 349:1591-1593.
10. Mills JL, McPartin JM, Kirke PN et al. Homocysteine metabolism in pregnancies complicated by neural tube defects. Lancet 1995; 345:149-151.
11. van der Put NMJ, van den Heuvel LP, Steegers-Theunissen RPM et al. Decreased methylene tetrahydrofolate reductase activity due to the 677C-T mutation in families with spring bifida offspring. J Mol Med 1996; 74; 691-694.
12. Kutzbach C, Stokstad ELR. Mammalian tetrahydrofolate reductase: Partial purification, properties and inhibition by S-adenosylmethionine. Biochem Biophys Acta 1971; 250: 459-477.